At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 203 enrolled
Drug / intervention
Polyethylene glycol 3350 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Placebo-Controlled, Double-Blind, Trial of Polyethylene Glycol 3350 Laxative for the Treatment of Occasional Constipation.
In Brief
A Phase 4 clinical trial evaluating Polyethylene glycol 3350 and Placebo, maltodextrin 500 powder for solution for Constipation. Completed, enrolled 203 participants.
Detailed Summary
Randomized, placebo-controlled, double blind study. 203 subjects entered the study to compare the effect on occasional constipation of polyethylene glycol 3350 to placebo. Subjects took one of study treatments up to 7 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConstipation
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
Primary CompletionJan 2008
First PostedOct 2008
TodayJul 2026
First PostedOct 10, 2008
Enrollment StartNov 1, 2007
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.7 years ago
Interventions
Polyethylene glycol 3350drug
Polyethylene glycol 3350 powder for solution. Single dose (17 grams in 4 to 8 ounces of beverage) for 7 days.
Placebo, maltodextrin 500 powder for solutionother
Maltodextrin 500 powder for solution, One single dose (one capful) in any 4 - 8 ounces beverage for 7 days.